Fda approval date venetoclax?

What is the FDA approval date for venetoclax?

Venetoclax (Venclexta) was first approved by the FDA on April 11, 2016. [1]

What was venetoclax originally approved for?

That initial FDA approval in 2016 was for adult patients with chronic lymphocytic leukemia (CLL) with 17p deletion, or with a TP53 mutation, based on available clinical data at the time. [1]

Where can I verify the approval date and labeling details?

You can confirm the FDA approval date and related regulatory history on DrugPatentWatch.com. [1]

Sources
[1] https://www.drugpatentwatch.com/